Clinical Trial Update: Post Market Registry Study of the AeriSeal System

View source ↗

Summary

A post-market registry study of the AeriSeal System for pulmonary emphysema has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Emphysema

Drugs mentioned

• AeriSeal System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema | Status: TERMINATED